TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395,243 | +1.8% | 25,549 | +3.4% | 0.08% | +8.2% |
| Q2 2023 | $388,273 | -3.3% | 24,715 | +1.5% | 0.07% | -11.0% |
| Q1 2023 | $401,337 | +9.5% | 24,353 | +3.7% | 0.08% | +3.8% |
| Q4 2022 | $366,475 | -4.6% | 23,492 | -20.7% | 0.08% | -14.1% |
| Q3 2022 | $384,000 | +34.3% | 29,634 | +45.5% | 0.09% | +29.6% |
| Q2 2022 | $286,000 | -1.7% | 20,370 | +0.1% | 0.07% | +9.2% |
| Q1 2022 | $291,000 | +4750.0% | 20,353 | +6684.3% | 0.06% | +3150.0% |
| Q1 2019 | $6,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
| Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
| Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
| GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
| MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
| TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
| Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
| Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
| Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
| DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |